title: [PEG-interferons: significance for the treatment of viral hepatitis B and C].
authors.affiliation: Abteilung Gastroenterologie und Hepatologie, Medizinischen Hochschule Hannover. h_wedemeyer@yahoo.com
authors.forename: H
authors.initials: H
authors.lastname: Wedemeyer
authors.forename: M
authors.initials: M
authors.lastname: Cornberg
authors.forename: M P
authors.initials: MP
authors.lastname: Manns
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008103:Liver Cirrhosis / Q000188:drug therapy / Q000209:etiology; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a